December 2, 2024
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Re: | Emergent BioSolutions Inc. |
Registration Statement on Form S-1
File No. 333-283150
Filed November 12, 2024
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Emergent BioSolutions Inc. hereby respectfully requests that the effective date for the above-referenced registration statement be accelerated to 4:00 p.m., Eastern Time, on December 4, 2024, or as soon as practicable thereafter.
Should you have any questions or comments regarding the foregoing, please contact Matthew C. Franker or Julie M. Plyler of Covington & Burling LLP at (202) 662-5895 or (212) 841-1090, respectively.
| Respectfully, | ||
| Emergent BioSolutions Inc. | ||
| By: | /s/ Jessica Perl | |
| Name: | Jessica Perl | |
| Title: | Senior Vice President, General Counsel and Corporate Secretary | |
| cc: | Tamika Sheppard |
Matthew C. Franker
Julie M. Plyler